Accelerating projects in
Clinical Research and
Market Access in
A WORD FROM OUR CEO, SARA TYLOSKY:
WHAT FARMACON CAN DO FOR YOU:
Farmacon Global’s strategic solutions accelerate clinical trials and market access in emerging markets – such as Latin America – through our on-the-ground medical associates and alliances, where every patient and every community counts… all to the benefit of our clients’ successful outcomes.
A database of privately and publicly funded clinical studies conducted around the world from 220 countries shows that there are 5,934 registered clinical studies in the Russian Federation and over 2,400 in Ukraine, not to mention over 300 in Belarus.